Literature DB >> 17214259

Tympanic reperforation in myringoplasty: evaluation of prognostic factors.

Roberto Albera1, Vittorio Ferrero, Michelangelo Lacilla, Andrea Canale.   

Abstract

OBJECTIVES: The most frequent failure in myringoplasty is reperforation. This complication appears at a rate of 7% to 27%. The aim of this study was to evaluate the importance of the principal prognostic factors to the risk of reperforation.
METHODS: This is a study of prognosis based on an inception cohort. The prognostic factors considered in the study refer to clinical and surgical aspects; follow-up ranged from 5 to 7 years (mean, 68 months). The study was performed on 212 patients with or without otorrhea who underwent operation for tympanic perforation. All subjects underwent myringoplasty by means of an underlay or overlay technique depending on the size and site of the perforation.
RESULTS: Healing of the tympanic perforation was obtained in 182 cases (86%). Age, otorrhea, status of the contralateral ear, and conductive hearing loss did not significantly affect the outcome of surgery. On the other hand, time from surgery, the site of perforation, the type of anesthesia, the approach, the surgical technique, and the type of graft were significantly related to the outcome.
CONCLUSIONS: In the analysis of our results, the surgical approach proved to be the principal prognostic factor in the anatomic outcome of myringoplasty. The results obtained suggest that the principal factors influencing the outcome of myringoplasty are technical and not clinical.

Entities:  

Mesh:

Year:  2006        PMID: 17214259     DOI: 10.1177/000348940611501202

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  14 in total

1.  Serum cotinine levels should optimally be measured when evaluating the outcomes of cartilage tympanoplasty in smokers.

Authors:  Xudan Lou; Zi-Han Lou
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-03-04       Impact factor: 2.503

2.  Study of Myringoplasty in Wet and Dry Ears in Mucosal Type of Chronic Otitis Media.

Authors:  U P Santosh; K B Prashanth; Ms Sudhakar Rao
Journal:  J Clin Diagn Res       Date:  2016-09-01

3.  Evaluation of middle ear risk index in patients undergoing tympanoplasty.

Authors:  Mahmood Shishegar; Mohammad Faramarzi; Mohsen Rashidi Ravari
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-07-17       Impact factor: 2.503

4.  Does Successful Myringoplasty Affect Eustachian Tube Function?

Authors:  Ramadan Hashem Sayed; Mostafa A Youssif; Khaled Abd El Rahman Ali; Dalia Talaat Ragheb; Khaled Gamal Dahy
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-04-02

5.  Scaffolds for tympanic membrane regeneration in rats.

Authors:  Yi Shen; Sharon Leanne Redmond; Bing Mei Teh; Sheng Yan; Yan Wang; Lin Zhou; Charley A Budgeon; Robert Henry Eikelboom; Marcus David Atlas; Rodney James Dilley; Minghao Zheng; Robert Jeffery Marano
Journal:  Tissue Eng Part A       Date:  2012-12-10       Impact factor: 3.845

6.  Simultaneous myringoplasty and septoplasty, and the use of nasal septal perichondrium.

Authors:  Cevat Uçar; Mustafa Kazkayasi
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-06       Impact factor: 2.503

Review 7.  Tympanoplasty in children.

Authors:  Saurav Sarkar; A Roychoudhury; B K Roychaudhuri
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-01-22       Impact factor: 2.503

8.  Study of Various Prognostic Factors Affecting Successful Myringoplasty in a Tertiary Care Centre.

Authors:  Kripa Dangol; Rakesh Prasad Shrivastav
Journal:  Int Arch Otorhinolaryngol       Date:  2016-11-28

9.  Evaluation of Factors Affecting the Surgical Outcome in Tympanoplasty.

Authors:  Masoud Naderpour; Yalda Jabbari Moghadam; Ensieh Ghanbarpour; Nikzad Shahidi
Journal:  Iran J Otorhinolaryngol       Date:  2016-03

10.  Comparison of Tympanoplasty Results in Dry and Wet Ears.

Authors:  Masoud Naderpour; Nikzad Shahidi; Taghi Hemmatjoo
Journal:  Iran J Otorhinolaryngol       Date:  2016-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.